Voltar
Artigo Acesso aberto Revisado por pares
BIBTEX RIS

Impact of the ESC Cardio-Oncology Guidelines Biomarker Criteria on Incidence of Cancer Therapy–Related Cardiac Dysfunction

2024; Elsevier BV; Volume: 6; Issue: 1 Linguagem: Inglês

10.1016/j.jaccao.2023.10.008

ISSN

2666-0873

Autores

Albulena Mecinaj, Geeta Gulati, Anne Hansen Ree, Berit Gravdehaug, Helge Røsjø, Kjetil Steine, Torbjørn Wisløff, Jürgen Geisler, Torbjørn Omland, Siri Lagethon Heck,

Tópico(s)

Acute Myocardial Infarction Research

Resumo

The impact of recent consensus definitions of cancer therapy-related cardiac dysfunction (CTRCD) from the European Society of Cardiology cardio-oncology guidelines on the reported incidence of CTRCD has not yet been assessed.

Referência(s)